Truveris Closes $3.8M Venture Capital Funding Round

Truveris, Inc., a New York-based health information technology company that provides management tools to sponsors of prescription benefit plans and payers of claims under these plans, has closed a $3.8m initial round of venture capital funding. 

The rounds was led by GSA Venture Partners, with participation from New Atlantic Ventures and First Round Capital.
The company intends to use the funds to expand product development and field operations in order to reach government entities, health insurance companies, self-insured corporations and unions across the country.
In conjunction with the funding, Steve Brotman of GSA Venture Partners and Scott Johnson of New Atlantic Ventures have joined the company’s board of directors.
Founded in 2009 and led by President Steven Marcus, Truveris provides solutions that are designed to help payers of pharmacy benefits validate claim payment accuracy, ensure regulatory compliance, and manage pharmacy spend.

Join the discussion